Roy Davis, was President, Johnson & Johnson Development Corporation (JJDC) and Vice President, Corporate Development, Johnson & Johnson, from January of 2008 until his retirement from J&J on January 1, 2012. In this role ,he was responsible for the management of JJDC , the Johnson & Johnson wholly owned ventures group, various corporate business development functions as well as the creation and management of Red Script Ventures,LLC (J&J's business accelerator). From September, 2003 until the end of 2007, Mr. Davis held the positions of Company Group Chairman, Johnson & Johnson and Worldwide Franchise Chairman, Ortho Clinical Diagnostics with responsibilities for Ortho Clinical Diagnostics, Inc., Veridex LLC, and Therakos, Inc. He was also a member of the Medical Devices & Diagnostics Group Operating Committee during this time. Prior to being named Company Group Chairman, Mr. Davis was named Group President, Therakos, Inc., Virco BVBA, Veridex, LLC, and Ortho Clinical Diagnostics, Inc., Advanced Research, New Technology, and New Market Development. From 1994 to 1999, Mr. Davis held the position of Vice President, Business Development and Strategic Planning for Ortho Diagnostic Systems worldwide, and later the combined Ortho Clinical Diagnostics, Inc. In 2000, he was named Group Vice President, Ortho Clinical Diagnostics, Inc., with responsibility for new business development and the newly formed Advanced Diagnostic Systems. Mr. Davis assumed additional responsibilities as President of Advanced Diagnostic Systems and Therakos, Inc., in July 2001. He subsequently was named President, Virco, BVBA, in September 2002 and he was named Chairman of the Joint Pharmaceutical, Diagnostic Virco Supervisory Board. Mr. Davis joined Johnson & Johnson in 1984 in the marketing department of Ortho Diagnostic Systems, Inc. In late 1988, Mr. Davis was named Managing Director of Ortho Diagnostic Systems, Northern Europe, with responsibility for the United Kingdom, Norway, Denmark, Sweden, Finland, and Ireland. In 1990, Mr. Davis was named President, Ortho Diagnostic Systems of Japan. In 1992, he was appointed Vice President, General Manager for Ortho Diagnostic Systems, United States, Canada, Latin America, and Export. Prior to joining Johnson & Johnson, Mr. Davis held progressively more responsible marketing positions with Warner-Lambert Company and Genetic Systems Corp. as well as management positions in the clinical laboratory industry. Mr. Davis received a Bachelor of Science from the State University of New York and a Master of Science from Rensselaer Polytechnic Institute.